P1012 (10266): Phase 1 Pharmacokinetic Study of Once- Versus Twice-Daily Zidovudine and Lamivudine

Study Status Study Restriction

Participants Off Study and Primary Analysis Completed

Not Applicable

Sites where the study is implemented:

CRS ID Site Name City Country
No records returned.

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.